HomeCompareBNRE vs JNJ

BNRE vs JNJ: Dividend Comparison 2026

BNRE yields 0.68% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BNRE wins by $608.00 in total portfolio value
10 years
BNRE
BNRE
● Live price
0.68%
Share price
$47.12
Annual div
$0.32
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.6K
Annual income
$70.98
Full BNRE calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BNRE vs JNJ

📍 BNRE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBNREJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BNRE + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BNRE pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BNRE
Annual income on $10K today (after 15% tax)
$57.72/yr
After 10yr DRIP, annual income (after tax)
$60.33/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $643.28/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BNRE + JNJ for your $10,000?

BNRE: 50%JNJ: 50%
100% JNJ50/50100% BNRE
Portfolio after 10yr
$20.3K
Annual income
$449.38/yr
Blended yield
2.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BNRE
No analyst data
Altman Z
0.4
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BNRE buys
0
JNJ buys
0
No recent congressional trades found for BNRE or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBNREJNJ
Forward yield0.68%3.36%
Annual dividend / share$0.32$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.6K$20.0K
Annual income after 10y$70.98$827.78
Total dividends collected$696.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BNRE vs JNJ ($10,000, DRIP)

YearBNRE PortfolioBNRE Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,768$67.91$10,676$355.77+$92.00BNRE
2$11,590$68.34$11,407$389.39+$183.00BNRE
3$12,470$68.75$12,198$426.53+$272.00BNRE
4$13,412$69.13$13,056$467.62+$356.00BNRE
5$14,420$69.49$13,987$513.12+$433.00BNRE
6$15,500$69.82$14,998$563.56+$502.00BNRE
7$16,655$70.14$16,098$619.52+$557.00BNRE
8$17,891$70.44$17,295$681.69+$596.00BNRE
9$19,214$70.71$18,599$750.82+$615.00BNRE
10$20,630$70.98$20,022$827.78+$608.00BNRE

BNRE vs JNJ: Complete Analysis 2026

BNREStock

Brookfield Asset Management Reinsurance Partners Ltd., through its subsidiaries, provides annuity-based reinsurance products to insurance and reinsurance companies. The company operates in two segments, Reinsurance and Pension Risk Transfer. It also acts as a direct issuer of pension risk transfer products for pension plan sponsors. The company was incorporated in 2020 and is headquartered in Pembroke, Bermuda.

Full BNRE Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BNRE vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BNRE vs SCHDBNRE vs JEPIBNRE vs OBNRE vs KOBNRE vs MAINBNRE vs ABBVBNRE vs MRKBNRE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.